IGC Pharma, Inc. (IGC) stock
IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/309% above fair value
$0.18−0.01 (-4.61%)
Close on Nov 13, 2026Market cap $18.20MP/E –Yield –
IGC Pharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
IGC Pharma's total debt was $128.00K at Sep 30, 2026. For fiscal 2026 it was $191.00K, up 39.4% from the year before. Over ten years it grew -13.7% a year on average. The highest annual figure on record is $1.80M in fiscal 2013.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $191.00K | +39.4% |
| FY2025 | Mar 31, 2025 | $137.00K | -2.1% |
| FY2024 | Mar 31, 2024 | $140.00K | -2.8% |
| FY2023 | Mar 31, 2023 | $144.00K | -2.0% |
| FY2022 | Mar 31, 2022 | $147.00K | -74.7% |
| FY2021 | Mar 31, 2021 | $580.00K | +1060.0% |
| FY2020 | Mar 31, 2020 | $50.00K | 0.0% |
| FY2019 | Mar 31, 2019 | $50.00K | – |
| FY2018 | Mar 31, 2018 | $0 | -100.0% |
| FY2017 | Mar 31, 2017 | $1.80M | +117.1% |
| FY2016 | Mar 31, 2016 | $829.23K | -48.3% |
| FY2015 | Mar 31, 2015 | $1.60M | – |
| FY2014 | Mar 31, 2014 | $0 | -100.0% |
| FY2013 | Mar 31, 2013 | $1.80M | +757.1% |
| FY2012 | Mar 31, 2012 | $210.01K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2027CQ4 2025 | Sep 30, 2026 | $128.00K | -5.9% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $149.00K | +9.6% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $191.00K | +39.4% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $134.00K | -2.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $136.00K | -1.4% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $136.00K | -2.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $137.00K | -2.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $137.00K | -2.8% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $138.00K | -2.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $139.00K | -2.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $140.00K | -2.8% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $141.00K | -2.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $142.00K | -2.1% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $143.00K | -2.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $144.00K | -2.0% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $144.00K | -2.7% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $145.00K | -2.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $146.00K | -2.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $147.00K | -74.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $148.00K | -74.5% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $149.00K | -74.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $150.00K | -76.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $580.00K | +1060.0% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $580.00K | +1060.0% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $580.00K | +1060.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $630.00K | +1160.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $50.00K | 0.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $50.00K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $50.00K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $50.00K | -85.7% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $50.00K | -71.6% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $0 | -100.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $0 | -100.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $350.79K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $175.99K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $1.80M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $446.00K | – |
See a number that looks wrong?